CAJ | 학술논문

目的：观察小儿肺热咳喘口服液在支气管肺炎辅助治疗的疗效及安全性。方法按照治疗方法将2010年10月～2012年10月入院治疗支气管肺炎的80例小儿患者分为两组，对照组40例静脉滴注头孢曲松钠，治疗组40例在对照组基础上使用小儿肺热咳喘口服液辅助治疗，疗程均为5～7d。结果治疗组小儿患者病情恢复指标均好于对照组（P＜0.05）；治疗组有效率为95.0%显著高于对照组有效率70.0%（P＜0.05）；治疗组中有1例患儿出现胃部不良反应，停药后病情恢复。结论支气管肺炎辅助小儿肺热咳喘口服液治疗，疗效显著，安全性好，临床应用前景广泛。
목적：관찰소인폐열해천구복액재지기관폐염보조치료적료효급안전성。방법안조치료방법장2010년10월～2012년10월입원치료지기관폐염적80례소인환자분위량조，대조조40례정맥적주두포곡송납，치료조40례재대조조기출상사용소인폐열해천구복액보조치료，료정균위5～7d。결과치료조소인환자병정회복지표균호우대조조（P＜0.05）；치료조유효솔위95.0%현저고우대조조유효솔70.0%（P＜0.05）；치료조중유1례환인출현위부불량반응，정약후병정회복。결론지기관폐염보조소인폐열해천구복액치료，료효현저，안전성호，림상응용전경엄범。
Objective To observe the efficacy and safety of pediatric Feire Kechuan oral liquid in adjuvant treatment of bronchial pneumonia. Methods According to the treatment method, 80 pediatric patients with bronchial pneumonia in our health-center from October 2010 to October 2012 were divided into two groups, 40 cases of the control group were treated by intravenous drip of ceftriaxone sodium, 40 cases of the treatment group were treated by pediatric Feire Kechuan oral liquid adjuvant therapy based on the treatment of control group, the course of treatment was 5-7 days. Results The clinical progress indicator of pediatric patients in the treatment group were better than the control group (P < 0.05).The effective rate of treatment group was 95% and significantly higher than 70.0% in control group (P<0.05). There was one pediatric patients had stomach adverse reactions, the illness recovered after drug withdrawal. Conclusion Pediatric the effect of Feire Kechuan oral liquid in adjuvant treatment of bronchial pneumonia is better. Security is good, with wide clinical application prospects.